Global Drug Based on Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Drug Based on Gene Therapy Industry Forecast” looks at past sales and reviews total world Drug Based on Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Based on Gene Therapy sales for 2023 through 2029. With Drug Based on Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Based on Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Drug Based on Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Based on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Based on Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Based on Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Based on Gene Therapy.
The global Drug Based on Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Based on Gene Therapy players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Based on Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Drug Based on Gene Therapy Industry Forecast” looks at past sales and reviews total world Drug Based on Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Based on Gene Therapy sales for 2023 through 2029. With Drug Based on Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Based on Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Drug Based on Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Based on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug Based on Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Based on Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Based on Gene Therapy.
The global Drug Based on Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Based on Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Based on Gene Therapy players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Based on Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Viral Gene Therapy
- Non-viral Gene Therapy
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Based on Gene Therapy Market Size 2018-2029
2.1.2 Drug Based on Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Based on Gene Therapy Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Drug Based on Gene Therapy Market Size by Type
2.3.1 Drug Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Drug Based on Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Drug Based on Gene Therapy Market Size by Application
2.5.1 Drug Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
3 DRUG BASED ON GENE THERAPY MARKET SIZE BY PLAYER
3.1 Drug Based on Gene Therapy Market Size Market Share by Players
3.1.1 Global Drug Based on Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drug Based on Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG BASED ON GENE THERAPY BY REGIONS
4.1 Drug Based on Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Based on Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drug Based on Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Drug Based on Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Drug Based on Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Based on Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Drug Based on Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Drug Based on Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Based on Gene Therapy by Country (2018-2023)
7.2 Europe Drug Based on Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Drug Based on Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Based on Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG BASED ON GENE THERAPY MARKET FORECAST
10.1 Global Drug Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Drug Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Drug Based on Gene Therapy Forecast
10.1.3 APAC Drug Based on Gene Therapy Forecast
10.1.4 Europe Drug Based on Gene Therapy Forecast
10.1.5 Middle East & Africa Drug Based on Gene Therapy Forecast
10.2 Americas Drug Based on Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Drug Based on Gene Therapy Market Forecast
10.2.2 Canada Drug Based on Gene Therapy Market Forecast
10.2.3 Mexico Drug Based on Gene Therapy Market Forecast
10.2.4 Brazil Drug Based on Gene Therapy Market Forecast
10.3 APAC Drug Based on Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Drug Based on Gene Therapy Market Forecast
10.3.2 Japan Drug Based on Gene Therapy Market Forecast
10.3.3 Korea Drug Based on Gene Therapy Market Forecast
10.3.4 Southeast Asia Drug Based on Gene Therapy Market Forecast
10.3.5 India Drug Based on Gene Therapy Market Forecast
10.3.6 Australia Drug Based on Gene Therapy Market Forecast
10.4 Europe Drug Based on Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Drug Based on Gene Therapy Market Forecast
10.4.2 France Drug Based on Gene Therapy Market Forecast
10.4.3 UK Drug Based on Gene Therapy Market Forecast
10.4.4 Italy Drug Based on Gene Therapy Market Forecast
10.4.5 Russia Drug Based on Gene Therapy Market Forecast
10.5 Middle East & Africa Drug Based on Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Drug Based on Gene Therapy Market Forecast
10.5.2 South Africa Drug Based on Gene Therapy Market Forecast
10.5.3 Israel Drug Based on Gene Therapy Market Forecast
10.5.4 Turkey Drug Based on Gene Therapy Market Forecast
10.5.5 GCC Countries Drug Based on Gene Therapy Market Forecast
10.6 Global Drug Based on Gene Therapy Forecast by Type (2024-2029)
10.7 Global Drug Based on Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Drug Based on Gene Therapy Product Offered
11.1.3 Biogen Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drug Based on Gene Therapy Product Offered
11.2.3 Novartis Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Drug Based on Gene Therapy Product Offered
11.3.3 Gilead Sciences Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Drug Based on Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Drug Based on Gene Therapy Product Offered
11.6.3 Amgen Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Drug Based on Gene Therapy Product Offered
11.7.3 Spark Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Drug Based on Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Drug Based on Gene Therapy Product Offered
11.9.3 bluebird bio Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Drug Based on Gene Therapy Product Offered
11.10.3 Sunway Biotech Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Drug Based on Gene Therapy Product Offered
11.11.3 SIBIONO Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Drug Based on Gene Therapy Product Offered
11.12.3 AnGes Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Drug Based on Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Drug Based on Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Based on Gene Therapy Market Size 2018-2029
2.1.2 Drug Based on Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug Based on Gene Therapy Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-viral Gene Therapy
2.3 Drug Based on Gene Therapy Market Size by Type
2.3.1 Drug Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Drug Based on Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Drug Based on Gene Therapy Market Size by Application
2.5.1 Drug Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
3 DRUG BASED ON GENE THERAPY MARKET SIZE BY PLAYER
3.1 Drug Based on Gene Therapy Market Size Market Share by Players
3.1.1 Global Drug Based on Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Drug Based on Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Drug Based on Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG BASED ON GENE THERAPY BY REGIONS
4.1 Drug Based on Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Drug Based on Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug Based on Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Drug Based on Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Drug Based on Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Drug Based on Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Based on Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Drug Based on Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Drug Based on Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug Based on Gene Therapy by Country (2018-2023)
7.2 Europe Drug Based on Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Drug Based on Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Based on Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG BASED ON GENE THERAPY MARKET FORECAST
10.1 Global Drug Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Drug Based on Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Drug Based on Gene Therapy Forecast
10.1.3 APAC Drug Based on Gene Therapy Forecast
10.1.4 Europe Drug Based on Gene Therapy Forecast
10.1.5 Middle East & Africa Drug Based on Gene Therapy Forecast
10.2 Americas Drug Based on Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Drug Based on Gene Therapy Market Forecast
10.2.2 Canada Drug Based on Gene Therapy Market Forecast
10.2.3 Mexico Drug Based on Gene Therapy Market Forecast
10.2.4 Brazil Drug Based on Gene Therapy Market Forecast
10.3 APAC Drug Based on Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Drug Based on Gene Therapy Market Forecast
10.3.2 Japan Drug Based on Gene Therapy Market Forecast
10.3.3 Korea Drug Based on Gene Therapy Market Forecast
10.3.4 Southeast Asia Drug Based on Gene Therapy Market Forecast
10.3.5 India Drug Based on Gene Therapy Market Forecast
10.3.6 Australia Drug Based on Gene Therapy Market Forecast
10.4 Europe Drug Based on Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Drug Based on Gene Therapy Market Forecast
10.4.2 France Drug Based on Gene Therapy Market Forecast
10.4.3 UK Drug Based on Gene Therapy Market Forecast
10.4.4 Italy Drug Based on Gene Therapy Market Forecast
10.4.5 Russia Drug Based on Gene Therapy Market Forecast
10.5 Middle East & Africa Drug Based on Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Drug Based on Gene Therapy Market Forecast
10.5.2 South Africa Drug Based on Gene Therapy Market Forecast
10.5.3 Israel Drug Based on Gene Therapy Market Forecast
10.5.4 Turkey Drug Based on Gene Therapy Market Forecast
10.5.5 GCC Countries Drug Based on Gene Therapy Market Forecast
10.6 Global Drug Based on Gene Therapy Forecast by Type (2024-2029)
10.7 Global Drug Based on Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Drug Based on Gene Therapy Product Offered
11.1.3 Biogen Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drug Based on Gene Therapy Product Offered
11.2.3 Novartis Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Drug Based on Gene Therapy Product Offered
11.3.3 Gilead Sciences Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Drug Based on Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Drug Based on Gene Therapy Product Offered
11.6.3 Amgen Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Drug Based on Gene Therapy Product Offered
11.7.3 Spark Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Drug Based on Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Drug Based on Gene Therapy Product Offered
11.9.3 bluebird bio Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Drug Based on Gene Therapy Product Offered
11.10.3 Sunway Biotech Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Drug Based on Gene Therapy Product Offered
11.11.3 SIBIONO Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Drug Based on Gene Therapy Product Offered
11.12.3 AnGes Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Drug Based on Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Drug Based on Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Drug Based on Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Based on Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Drug Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Drug Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Drug Based on Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drug Based on Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Drug Based on Gene Therapy Key Players Head office and Products Offered
Table 13. Drug Based on Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Based on Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drug Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Drug Based on Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drug Based on Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drug Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drug Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Drug Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Drug Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drug Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drug Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drug Based on Gene Therapy
Table 45. Key Market Challenges & Risks of Drug Based on Gene Therapy
Table 46. Key Industry Trends of Drug Based on Gene Therapy
Table 47. Global Drug Based on Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drug Based on Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drug Based on Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 52. Biogen Drug Based on Gene Therapy Product Offered
Table 53. Biogen Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 57. Novartis Drug Based on Gene Therapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 62. Gilead Sciences Drug Based on Gene Therapy Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Drug Based on Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 77. Amgen Drug Based on Gene Therapy Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 82. Spark Therapeutics Drug Based on Gene Therapy Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 87. Akcea Therapeutics Drug Based on Gene Therapy Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 92. bluebird bio Drug Based on Gene Therapy Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 97. Sunway Biotech Drug Based on Gene Therapy Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Drug Based on Gene Therapy Product Offered
Table 103. SIBIONO Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 107. AnGes Drug Based on Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Drug Based on Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 117. Human Stem Cells Institute Drug Based on Gene Therapy Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
Table 1. Drug Based on Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Therapy
Table 3. Major Players of Non-viral Gene Therapy
Table 4. Drug Based on Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 7. Drug Based on Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Drug Based on Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Drug Based on Gene Therapy Revenue Market Share by Player (2018-2023)
Table 12. Drug Based on Gene Therapy Key Players Head office and Products Offered
Table 13. Drug Based on Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Based on Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Drug Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Drug Based on Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Drug Based on Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Drug Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Drug Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Drug Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Drug Based on Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Drug Based on Gene Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Drug Based on Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Drug Based on Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Drug Based on Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Drug Based on Gene Therapy
Table 45. Key Market Challenges & Risks of Drug Based on Gene Therapy
Table 46. Key Industry Trends of Drug Based on Gene Therapy
Table 47. Global Drug Based on Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Drug Based on Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Drug Based on Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 52. Biogen Drug Based on Gene Therapy Product Offered
Table 53. Biogen Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 57. Novartis Drug Based on Gene Therapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 62. Gilead Sciences Drug Based on Gene Therapy Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Drug Based on Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Drug Based on Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 77. Amgen Drug Based on Gene Therapy Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 82. Spark Therapeutics Drug Based on Gene Therapy Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 87. Akcea Therapeutics Drug Based on Gene Therapy Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. bluebird bio Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 92. bluebird bio Drug Based on Gene Therapy Product Offered
Table 93. bluebird bio Main Business
Table 94. bluebird bio Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 97. Sunway Biotech Drug Based on Gene Therapy Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Drug Based on Gene Therapy Product Offered
Table 103. SIBIONO Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 107. AnGes Drug Based on Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Drug Based on Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Drug Based on Gene Therapy Area Served and Its Competitors
Table 117. Human Stem Cells Institute Drug Based on Gene Therapy Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Drug Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Drug Based on Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Based on Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drug Based on Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drug Based on Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Drug Based on Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drug Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Drug Based on Gene Therapy in Neurological Diseases
Figure 11. Global Drug Based on Gene Therapy Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Drug Based on Gene Therapy in Cancer
Figure 13. Global Drug Based on Gene Therapy Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Drug Based on Gene Therapy in Other
Figure 15. Global Drug Based on Gene Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Drug Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Drug Based on Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Drug Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drug Based on Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drug Based on Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Drug Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Drug Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drug Based on Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Drug Based on Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Based on Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drug Based on Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drug Based on Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Drug Based on Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drug Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Drug Based on Gene Therapy in Neurological Diseases
Figure 11. Global Drug Based on Gene Therapy Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Drug Based on Gene Therapy in Cancer
Figure 13. Global Drug Based on Gene Therapy Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Drug Based on Gene Therapy in Other
Figure 15. Global Drug Based on Gene Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Drug Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Drug Based on Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Drug Based on Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drug Based on Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drug Based on Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drug Based on Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Drug Based on Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Drug Based on Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drug Based on Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drug Based on Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drug Based on Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Drug Based on Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Drug Based on Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
